Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Back
Share this video  

iwNHL 2015 | iwNHL 2015 roundtable: Novel therapeutic combinations for relapsed/refractory T-cell lymphoma

Francesco d'Amore, Francine Foss, Laurence de Leval and Owen O'Connor • 3 Oct 2015

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Francine M. Foss, MD, of the Yale University School of Medicine, New Haven, CT, chairs a discussion with Laurence de Leval, MD, PhD, of Institut universitaire de pathologie, Lausanne, Switzerland, Francesco d’Amore, MD, PhD of Aarhus University Hospital, Aarhus, Denmark, and Owen A. O’Connor, MD, PhD, Columbia University, New York, NY. Dr O’Connor summarises the current evidence on novel therapies, with an emphasis on combination regimens, for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.